| Activated and exhausted MAIT cells foster disease progression and indicate poor outcome in hepatocellular carcinoma M Duan, S Goswami, JY Shi, LJ Wu, XY Wang, JQ Ma, Z Zhang, Y Shi, ... Clinical Cancer Research 25 (11), 3304-3316, 2019 | 133 | 2019 |
| CCL 15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma LZ Liu, Z Zhang, BH Zheng, Y Shi, M Duan, LJ Ma, ZC Wang, LQ Dong, ... Hepatology 69 (1), 143-159, 2019 | 124 | 2019 |
| Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression G Song, Y Shi, M Zhang, S Goswami, S Afridi, L Meng, J Ma, Y Chen, ... Cell Discovery 6 (1), 90, 2020 | 102 | 2020 |
| Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma LQ Dong, Y Shi, LJ Ma, LX Yang, XY Wang, S Zhang, ZC Wang, M Duan, ... Journal of hepatology 69 (1), 89-98, 2018 | 76 | 2018 |
| Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma G Song, Y Shi, L Meng, J Ma, S Huang, J Zhang, Y Wu, J Li, Y Lin, S Yang, ... Nature communications 13 (1), 1642, 2022 | 61 | 2022 |
| Mutational spectrum and precision oncology for biliary tract carcinoma J Lin, Y Cao, X Yang, G Li, Y Shi, D Wang, J Long, Y Song, J Mao, F Xie, ... Theranostics 11 (10), 4585, 2021 | 48 | 2021 |
| The dynamic cellular landscape of grafts with acute rejection after heart transplantation D Kong, S Huang, X Miao, J Li, Z Wu, Y Shi, H Liu, Y Jiang, X Yu, M Xie, ... The Journal of Heart and Lung Transplantation 42 (2), 160-172, 2023 | 9 | 2023 |
| Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors Y Shi, B Jing, R Xi Genome Biology 24 (1), 169, 2023 | 7 | 2023 |
| Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors D Ye, J Desai, J Shi, SYM Liu, W Shen, T Liu, Y Shi, D Wang, L Liang, ... Biomarker Research 11 (1), 1-12, 2023 | 6 | 2023 |
| The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma Z Lu, S Yang, X Luo, Y Shi, JS Lee, S Deva, T Liu, Y Chao, Y Zhang, ... Gastric Cancer 25 (5), 943-955, 2022 | 6 | 2022 |
| Evaluation of the EdgeSeq Precision Immuno-Oncology Panel for gene expression profiling from clinical formalin-fixed paraffin-embedded tumor specimens Y Shi, X Ma, W Shen, T Liu, L Liang, S Liu, Z Shen, Y Zhang, P Zhang Frontiers in Cell and Developmental Biology 10, 899353, 2022 | 5 | 2022 |
| Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study JR Brown, J Li, BF Eichhorst, N Lamanna, SM O'Brien, CS Tam, L Qiu, ... Blood 142, 1890, 2023 | 4 | 2023 |
| TAGET: a toolkit for analyzing full-length transcripts from long-read sequencing Y Xia, Z Jin, C Zhang, L Ouyang, Y Dong, J Li, L Guo, B Jing, Y Shi, ... Nature Communications 14 (1), 5935, 2023 | 3 | 2023 |
